SG129272A1 - Molecules, compositions, methods and kits for applications associated with flaviviruses - Google Patents

Molecules, compositions, methods and kits for applications associated with flaviviruses

Info

Publication number
SG129272A1
SG129272A1 SG200400300A SG200400300A SG129272A1 SG 129272 A1 SG129272 A1 SG 129272A1 SG 200400300 A SG200400300 A SG 200400300A SG 200400300 A SG200400300 A SG 200400300A SG 129272 A1 SG129272 A1 SG 129272A1
Authority
SG
Singapore
Prior art keywords
flaviviruses
kits
methods
compositions
molecules
Prior art date
Application number
SG200400300A
Inventor
Mah Lee Mary Ng
Jang Hann Justin Chu
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Publication of SG129272A1 publication Critical patent/SG129272A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A method for controlling a flavivirus entry into a cell, kits for assaying the flavivirus entry into the cell, and methods of treating and preventing flaviviruses infections are disclosed, together with vaccine and pharmaceutical compositions.
SG200400300A 2003-01-22 2004-01-21 Molecules, compositions, methods and kits for applications associated with flaviviruses SG129272A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44215703P 2003-01-22 2003-01-22

Publications (1)

Publication Number Publication Date
SG129272A1 true SG129272A1 (en) 2007-02-26

Family

ID=38645694

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2007053978A SG172479A1 (en) 2003-01-22 2004-01-21 Molecules, compositions, methods and kits for applications associated with flaviviruses
SG200400300A SG129272A1 (en) 2003-01-22 2004-01-21 Molecules, compositions, methods and kits for applications associated with flaviviruses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2007053978A SG172479A1 (en) 2003-01-22 2004-01-21 Molecules, compositions, methods and kits for applications associated with flaviviruses

Country Status (1)

Country Link
SG (2) SG172479A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046264A1 (en) * 1997-04-11 1998-10-22 G.D. Searle & Co. Antagonistic anti-avb3 integrin antibodies

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046264A1 (en) * 1997-04-11 1998-10-22 G.D. Searle & Co. Antagonistic anti-avb3 integrin antibodies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF INFECTIOUS DISEASES, 186(6) *
JOURNAL OF VIROLOGY, 74(16) *
JOURNAL OF VIROLOGY, 74(19) *
NATURE MEDICINE, 3(8) *

Also Published As

Publication number Publication date
SG172479A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
IL249263B (en) Method for ex-vivo organ care
EP1483281A4 (en) Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
NO20082305L (en) Microbiologically stabilized, etc.
TW200517381A (en) Bicyclic heteroaryl derivatives
MY142777A (en) Substituted indole-o-glucosides
WO2005041752A3 (en) Bone plate and method for using bone plate
WO2006085149A3 (en) Methods and compositions for treating amyloid-related diseases
UA87991C2 (en) Substituted indole-o-glucosides
ATE434639T1 (en) AQUEOUS DISPERSIONS OF SILICONE POLYETHER BLOCK COPOLYMERS
HK1093088A1 (en) Block for construction, panel for construction using the block, and method of molding panel for construction
WO2003101397A3 (en) Tetravalent dengue vaccines
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
BRPI0516034A (en) production method of a composition
MX2007007613A (en) Pharmaceutical formulations.
UA107443C2 (en) Chemical method
WO2009131730A3 (en) IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
NO20053595L (en) Escitalopram dibromide and its process.
MX2007010007A (en) Apparatus and method for the production of hydrogen.
NO20055830D0 (en) Proglitazone salts, such as pioglitazone sulfate and pharmaceutical compositions and methods using the same
MX2007005202A (en) Modified streptococcal polysaccharides and uses thereof.
WO2003103571A3 (en) Flavivirus vaccines
TW200507840A (en) Method of treating multiple myeloma
PL1735369T3 (en) Fast curing polydiorganosiloxanes
BRPI0415164A (en) device for administering a biotherapeutic composition, biotherapeutic composition, method of preparing a biotherapeutic composition, treatment method, and dispenser